Global varicella vaccination programs
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Young Hwa | - |
dc.contributor.author | Choe, Young June | - |
dc.contributor.author | Lee, Jia | - |
dc.contributor.author | Kim, Eunseong | - |
dc.contributor.author | Lee, Jae Young | - |
dc.contributor.author | Hong, Kwan | - |
dc.contributor.author | Yoon, Yoonsun | - |
dc.contributor.author | Kim, Yun-Kyung | - |
dc.date.accessioned | 2023-02-02T02:40:03Z | - |
dc.date.available | 2023-02-02T02:40:03Z | - |
dc.date.issued | 2022-12 | - |
dc.identifier.issn | 2713-4148 | - |
dc.identifier.issn | 2713-4148 | - |
dc.identifier.uri | https://scholarworks.korea.ac.kr/kumedicine/handle/2021.sw.kumedicine/62322 | - |
dc.description.abstract | Varicella (chickenpox) is an infectious disease caused by the highly contagious varicella zoster virus with a secondary attack rate greater than 90%. From this perspective, we aimed to establish the basis for a national varicella vaccine policy by reviewing vaccination programs and policies of countries that have introduced universal varicella vaccinations. As a result of the spread of varicella, an increasing number of countries are providing 2-dose vaccinations and universally expanding their use. In practice, the efficacy and effectiveness of vaccination differ among vaccines and vaccination programs. Optimized vaccination strategies based on each country's local epidemiology and health resources are required. Accordingly, it is necessary to evaluate the effectiveness of varicella vaccines in different settings. Given the short-term and fragmented vaccine effectiveness evaluation in Korea, it is necessary to evaluate its effectiveness at the national level and determine its schedule based on the evidence generated through these studies. | - |
dc.format.extent | 8 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | 대한소아청소년과학회 | - |
dc.title | Global varicella vaccination programs | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.doi | 10.3345/cep.2021.01564 | - |
dc.identifier.scopusid | 2-s2.0-85143233117 | - |
dc.identifier.wosid | 000906540700001 | - |
dc.identifier.bibliographicCitation | Clinical and Experimental Pediatrics, v.65, no.12, pp 555 - 562 | - |
dc.citation.title | Clinical and Experimental Pediatrics | - |
dc.citation.volume | 65 | - |
dc.citation.number | 12 | - |
dc.citation.startPage | 555 | - |
dc.citation.endPage | 562 | - |
dc.type.docType | Review | - |
dc.identifier.kciid | ART002904726 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Pediatrics | - |
dc.relation.journalWebOfScienceCategory | Pediatrics | - |
dc.subject.keywordPlus | UNITED-STATES | - |
dc.subject.keywordPlus | CHILDREN | - |
dc.subject.keywordPlus | IMPACT | - |
dc.subject.keywordPlus | IMMUNIZATION | - |
dc.subject.keywordPlus | GERMANY | - |
dc.subject.keywordPlus | IMPLEMENTATION | - |
dc.subject.keywordPlus | EPIDEMIOLOGY | - |
dc.subject.keywordPlus | PREVENTION | - |
dc.subject.keywordPlus | OUTBREAK | - |
dc.subject.keywordAuthor | Varicella | - |
dc.subject.keywordAuthor | Chickenpox | - |
dc.subject.keywordAuthor | Vaccination | - |
dc.subject.keywordAuthor | Immunization programs | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265
COPYRIGHT 2020 KOREA UNIVERSITY MEDICAL LIBRARY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.